The U.S. Food and Drug Administration (FDA) has cleared artificial intelligence (AI) software developer RapidAI's CT imaging stroke assessment software.
Rapid NCCT Stroke helps detect suspected intracranial hemorrhage and large vessel occlusion on noncontrast CT imaging. It delivers triage and prioritization notifications through PACS and email, and it supports clinicians' efforts to make workflow and patient care decisions more quickly. It may also reduce the time between CT and CT angiography exams, according to the firm.
